Antimicrobial peptides in the airway

Area of Science:

• Immunology
• Microbiology
• Respiratory Medicine

Background:

• The airway surface fluid (ASF) contains antimicrobial peptides and proteins crucial for respiratory defense.
• Key components include lysozyme, lactoferrin, defensins, and cathelicidins, which combat airborne microbes.
• Some peptides like human beta-defensin (hBD)-1 are constitutive, while others (hBD2, hBD3) are inducible via Toll-like receptor pathways.

Purpose of the Study:

• To elucidate the multifaceted role of antimicrobial peptides and proteins in airway host defense.
• To investigate factors that inhibit antimicrobial peptide activity and gene expression.
• To explore therapeutic strategies targeting peptide modulation for airway infections.

Main Methods:

• Review of existing literature on airway antimicrobial peptides and proteins.
• Analysis of mechanisms underlying peptide induction and inhibition.
• Examination of disease models (e.g., cystic fibrosis) and environmental factors affecting peptide function.

Main Results:

• Antimicrobial peptides exhibit microbicidal and immune cell chemotaxis functions in the ASF.
• Inhibition of peptide activity or expression elevates susceptibility to respiratory infections.
• Pathogens and environmental factors like air pollution can suppress defensin gene expression.

Conclusions:

• Antimicrobial peptides are vital for airway innate immunity, with complex roles beyond direct microbial killing.
• Dysregulation of these peptides, as seen in cystic fibrosis, compromises airway defense.
• Targeting peptide gene expression and developing peptide-based therapeutics offer promising avenues for treating airway infections.